目的评价孕妇产前应用乙型肝炎免疫球蛋白(hepatitis Bimmune globulin,HBIG)阻断乙型肝炎病毒(hepatitis B virus,HBV)宫内传播的效果。方法查阅国内外有关孕妇产前使用HBIG阻断宫内传播的研究,收集出生及1岁婴儿乙肝表面抗原(hepatitis B surface antigen,HBsAg)检测情况,通过Stata12.0软件进行Meta分析,获得合并RR值。结果新生儿随机效应模型干预组与对照组合并RR值为0.37,95%CI:0.23—0.61;1岁婴儿随机效应模型干预组与对照组合并RR值为0.48,95%CI:0.27~0.84。结论应用HBIG200IU可以有效阻断乙肝病毒的官内传播。
Objective To evaluate the effects of hepatitis B immunoglobulin (HBIG) intrauterine-injection before delivery on interrupting mother-to-child transmission of hepatitis B virus (HBV). Methods The randomized controlled tri- Ms on HBIG intrauterine injection on interrupting mother-to-child transmission of HBV published from January 1995 to May 2013 were searched. The data were extracted and analyzed by STATA software. Results Results of the meta-analysis indi- cated that the infant HBV infection relative risks with random effects models in the HBIG group and the control group were 0.37(95% Cl:0. 23-0. 61) at birth ,O. 48(95% CI:0.27-0.84)on 1 year. Conclusions Injection of HBIG during pregnancy with possitive HBV can effectively reduce the vertical transmission of HBV.